Traders ditch derivatives for broker-funded stock bets

Rapport Therapeutics director Paul Silva buys $99,636 in stock

Investing.com · News 13m ago

SpaceX records $561 million investment gain from stake in Elon Musk's Boring Co.

CNBC · Markets 17m ago

Rapport Therapeutics director Wendy Young buys $99,991 in shares

Investing.com · News 17m ago

Buckle SVP stores Scott Werth sells $116,870 in common stock

Investing.com · News 17m ago

Rapport Therapeutics director Paul M. buys $974k in shares

Investing.com · News 17m ago

Rapport Therapeutics director John Maraganore acquires $248,891 in stock

Investing.com · News 17m ago

Japanese Bond Yields Fall as AI Jitters Spur Haven Demand

Bloomberg · Markets 20m ago

Microsoft develops AI tool that can diagnose ’sequentially’ like a doctor

Investing.com · News 20m ago

Oil prices cool from 5-month highs as Trump invokes defense production act

Investing.com · News 21m ago

Earnings call transcript: ikeGPS Group flags stronger second half in Q2 2026

Investing.com · News 23m ago